REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Compounds

Browse research peptides and FDA-approved peptide drugs. Choose a database below.

65+

Peptide Library

Research reference for every compound — mechanisms, protocols, half-lives, storage, and legal status.

Browse →
49

FDA Drugs

FDA-registered peptide and peptide-derived drugs. GLP-1 agonists, growth hormone, insulin, GnRH analogs, and more.

Browse →